LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus

Summary

The rationale of the study is to determine: * the first dose and the titration of basal insulin * the exact daily time administration of basal insulin in poorly controlled type II diabetic patients.

Timeline

Start

2006-09

Primary completion

2007-06

Completion

—

Outcome

Outcome not reported

Stopped: “prematurely terminated due to loss of interest”

Drugs

Indications